NTRA
Natera Inc
NASDAQ: NTRA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$194.75
-2.71% today
Updated 2026-04-29
Market cap
$27.81B
P/E ratio
—
P/S ratio
12.06x
EPS (TTM)
$-1.52
Dividend yield
—
52W range
$132 – $256
Volume
1.3M
Natera Inc (NTRA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-9.03%
Operating margin
-3.42%
ROE
-14.30%
ROA
-9.54%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $14.25M | $-76.17M | 21.74% | -134.84% | -534.53% |
| 2013 | $55.17M | $-37.11M | 32.44% | -45.80% | -67.26% |
| 2014 | $159.29M | $-5.15M | 50.78% | 0.42% | -3.23% |
| 2015 | $190.35M | $-70.28M | 40.72% | -31.43% | -36.92% |
| 2016 | $217.07M | $-95.77M | 37.54% | -44.45% | -44.12% |
| 2017 | $210.94M | $-136.31M | 33.82% | -63.54% | -64.62% |
| 2018 | $257.65M | $-128.15M | 35.55% | -44.49% | -49.74% |
| 2019 | $302.33M | $-124.83M | 41.96% | -38.46% | -41.29% |
| 2020 | $391.00M | $-229.74M | 47.92% | -55.31% | -58.76% |
| 2021 | $625.49M | $-471.72M | 49.09% | -74.85% | -75.42% |
| 2022 | $820.22M | $-547.80M | 44.37% | -65.96% | -66.79% |
| 2023 | $1.08B | $-434.80M | 45.52% | -41.22% | -40.16% |
| 2024 | $1.70B | $-190.43M | 60.30% | -13.10% | -11.22% |
| 2025 | $2.31B | $-208.16M | 64.85% | -13.44% | -9.03% |